2-[[4,5-dihydroxy-6-(hydroxymethyl)-3-[[2-[[(2E,4E)-4,6,14-trimethylhexadeca-2,4-dienoyl]amino]acetyl]amino]oxan-2-yl]oxy-hydroxyphosphoryl]oxy-4-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoic acid

Term ID

CHEBI:226508

Synonyms

2-[[4,5-dihydroxy-6-(hydroxymethyl)-3-[[2-[[(2E,4E)-4,6,14-trimethylhexadeca-2,4-dienoyl]amino]acetyl]amino]oxan-2-yl]oxy-hydroxyphosphoryl]oxy-4-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxa

Definition

References

Chemspider:78445321

Ontology

ChEBI ( EBI )

Relationships

is a type of: N-acyl-hexosamine

N-acyl-hexosamine Show first 5 Terms

Phenotype

Phenotype resulting from 2-[[4,5-dihydroxy-6-(hydroxymethyl)-3-[[2-[[(2E,4E)-4,6,14-trimethylhexadeca-2,4-dienoyl]amino]acetyl]amino]oxan-2-yl]oxy-hydroxyphosphoryl]oxy-4-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoic acid

Phenotype where environments contain 2-[[4,5-dihydroxy-6-(hydroxymethyl)-3-[[2-[[(2E,4E)-4,6,14-trimethylhexadeca-2,4-dienoyl]amino]acetyl]amino]oxan-2-yl]oxy-hydroxyphosphoryl]oxy-4-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoic acid

Phenotype modified by environments containing 2-[[4,5-dihydroxy-6-(hydroxymethyl)-3-[[2-[[(2E,4E)-4,6,14-trimethylhexadeca-2,4-dienoyl]amino]acetyl]amino]oxan-2-yl]oxy-hydroxyphosphoryl]oxy-4-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutanoic acid

Human Disease Model